CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Analysis of Bioanalytical Services Market

Analysis of Bioanalytical Services...

Trudiagnostic Unveils Truage PACE For Tracking Biological Aging Rate

Trudiagnostic Unveils Truage PACE For...

Know More About the Comprehensive Bioanalytical Testing Services

Know More About the Comprehensive...

Ways Bioanalytical Laboratory Automation Boosts Efficiency and Accuracy

Ways Bioanalytical Laboratory...

Analytics' Role in Pharmaceutical Success

Analytics' Role in Pharmaceutical...

Discovering and developing drugs using bioanalysis

Discovering and developing drugs...

Developing Next-Generation Technologies for a Better Tomorrow

Developing Next-Generation...

Why Outsource Bioanalysis Work?

Why Outsource Bioanalysis Work?

Analysis of Bioanalytical Services Market

Analysis of Bioanalytical Services...

Trudiagnostic Unveils Truage PACE For Tracking Biological Aging Rate

Trudiagnostic Unveils Truage PACE For...

Know More About the Comprehensive Bioanalytical Testing Services

Know More About the Comprehensive...

Ways Bioanalytical Laboratory Automation Boosts Efficiency and Accuracy

Ways Bioanalytical Laboratory...

Analytics' Role in Pharmaceutical Success

Analytics' Role in Pharmaceutical...

Discovering and developing drugs using bioanalysis

Discovering and developing drugs...

Developing Next-Generation Technologies for a Better Tomorrow

Developing Next-Generation...

Why Outsource Bioanalysis Work?

Why Outsource Bioanalysis Work?

Clinical Research Technology Leader RealTime Secures Growth Investment from LLR Partners

Life Sciences Review | Friday, January 21, 2022
Tweet

San Antonio – RealTime Software Solutions, LLC, a leader in cloud-based software solutions for the clinical research industry, today announced a significant growth investment from LLR Partners. The capital and resources from this partnership will be dedicated to helping accelerate the company’s growth, product innovation and delivery of world-class customer experiences.


RealTime is dedicated to solving problems and providing systems that make the clinical research process more efficient and compliant. The company’s complete Site Operations Management System (SOMS) enables research sites to run better, recruit faster and perform higher through solutions including a Clinical Trial Management System (CTMS), eRegulatory document management (eDOCS), electronic data capture for source documents (eSOURCE), participant payments (SitePAY/GlobalPAY) and participant engagement (TEXT).


“Our vision at RealTime is to reshape the global clinical research industry with innovative solutions that help advance medicine and save lives,” said Rick Greenfield, Founder & CEO of RealTime. “LLR Partners has a long history of investing and supporting the growth of pharma services and technology businesses. As partners, we will be able to access a deep set of resources and experiences to help us deliver enhanced solutions to our customers and enable new pharmaceutical treatments to reach the world at an even faster pace.”


See Also:


Real Estate Business Review 


“The critical work being done by the clinical research industry to improve and save lives has never been more prominent,” said Zack Sigal, Principal at LLR Partners. “RealTime is a leader in the dynamic clinical research technology market with a talented, passionate team dedicated to this purpose. We are excited to partner with Rick Greenfield, Scott Butcher (COO) and their entire team as the company continues to improve the way research sites operate through technology innovation.”


Rick Riegel, a multi-time private equity-backed CEO in pharma technology and services, will join the Board of Directors of RealTime, along with Scott Perricelli and Zack Sigal from LLR Partners. Riegel is a Senior Operating Advisor engaged by LLR and currently serves as Chairman of ActiGraph and Deerfield Agency and previously served as CEO of Phlexglobal and LIQUENT.


Crosstree Capital Partners served as the exclusive financial advisor to RealTime Software Solutions in this transaction.


Weekly Brief

loading
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/clinical-research-technology-leader-realtime-secures-growth-investment-from-llr-partners-nwid-699.html